Qube Research & Technologies (QRT)’s Clovis Oncology, Inc. CLVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,980	Closed	-$632	–	3197
2022 Q4	$632	Sell	11,980 -8,098	-40%	-$5.33K	﹤0.01%	2385
2022 Q3	$24K	Buy	+20,078	New	+$31.3K	﹤0.01%	2275
2022 Q2	–	Sell	-491,036	Closed	-$992K	–	3316
2022 Q1	$992K	Buy	491,036 +435,372	+782%	+$855K	0.01%	1175
2021 Q4	$151K	Buy	+55,664	New	+$206K	﹤0.01%	2050

Other funds holding CLVS

RMC

Resources Management Corp West Hartford, Connecticut $794M AUM 25.46% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLVS Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 11,980 shares — an estimated $632 sold.

Qube Research & Technologies (QRT) first reported a position in CLVS in Q4 2021 and held it in 4 quarters. The position peaked at $992K in Q1 2022. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

Qube Research & Technologies (QRT) reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 11,980 Clovis Oncology, Inc. shares in Q1 2023, an estimated $632.
Qube Research & Technologies (QRT) first reported a position in Clovis Oncology, Inc. in Q4 2021 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Clovis Oncology, Inc. position peaked at $992K in Q1 2022.
2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.